Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FGEN3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $16,584.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, awarded on November 20, 2025, with an ultimate completion date of December 12, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was made without subcontractor involvement, with performance to occur at the vendor's Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply diverse pharmaceutical products to Department of Defense military healthcare facilities worldwide. The underlying IDC, designated SPE2DR and awarded November 13, 2025, has a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. DMS Pharmaceutical Group's established performance across multiple delivery orders encompassing a comprehensive range of branded and generic prescription medications, biologics, and medical consumables positions the contractor as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FGEN3?
SPE2DR26FGEN3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FGEN3 worth?
The government has obligated $16,584 on SPE2DR26FGEN3.
Is contract SPE2DR26FGEN3 an order under another contract?
Yes. SPE2DR26FGEN3 is a delivery order under SPE2DR25D9312, an indefinite delivery contract.
Was contract SPE2DR26FGEN3 competed?
The extent of competition for SPE2DR26FGEN3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award